← Leaderboards
Haojie Zhu
University Of Michigan At Ann Arbor
$5,215,229
Attributed
$6,690,268
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2015–24$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,690,268 · 5
By mechanism
R01$5,834,829 · 3
R21$855,439 · 2
Top collaborators
- John S Markowitz5 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Benjamin Eric Tourdot$2,288,313
- Stephen Weiss$24,277,384
- Andrew David White$662,877
- Wei C Lau$27,349
- Richard A. Miller$53,224,142
Others in their field
Top investigators on “Metabolism”
- David M Nathan · Massachusetts Institute Of Technology$157,845,616
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$144,157,234
- Judith S. Currier · University Of California Los Angeles$141,260,706
- John M Lachin · George Washington University$139,991,329
- Randall J Bateman · Washington University$124,168,384
- Carol Nesel · Westat$116,355,411
Research focus
MetabolismAffectPharmaceutical PreparationsDrug KineticsPharmacotherapySafetyRitalinVariantResponseDoseHepaticGenesGenetic VariantPharmacogeneticsOralTherapy OutcomeIn VitroCarboxylesterase 1LiverPharmacodynamicsHealthy VolunteerExpectationAdverse EffectsHydrolase
Grant awards (17)
Carboxylesterase 1 Plasma Biomarker for Precision Pharmacotherapy$312,000
R01 · FY2024 · GM · contact PI
Carboxylesterase 1 Plasma Biomarker for Precision Pharmacotherapy$312,000
R01 · FY2023 · GM · contact PI
Modifying Remdesivir Prodrug Design to Enhance the Active Metabolite Accumulation in the Lung (Resubmission)$195,000
R21 · FY2023 · AI · contact PI
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD$541,213
R01 · FY2022 · HD
Carboxylesterase 1 Plasma Biomarker for Precision Pharmacotherapy$312,000
R01 · FY2022 · GM · contact PI
Modifying Remdesivir Prodrug Design to Enhance the Active Metabolite Accumulation in the Lung (Resubmission)$234,000
R21 · FY2022 · AI · contact PI
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD$566,998
R01 · FY2021 · HD
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD$575,390
R01 · FY2020 · HD
Genetic determinants of ACEI prodrug activation$387,000
R01 · FY2020 · HL · contact PI
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD$588,857
R01 · FY2019 · HD
Genetic determinants of ACEI prodrug activation$387,000
R01 · FY2019 · HL · contact PI
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD$677,621
R01 · FY2018 · HD
Genetic determinants of ACEI prodrug activation$387,000
R01 · FY2018 · HL · contact PI
Genetic determinants of ACEI prodrug activation$387,000
R01 · FY2017 · HL · contact PI
Genetic determinants of ACEI prodrug activation$400,750
R01 · FY2016 · HL · contact PI
CES1 variants as determinant of ACE inhibitor activation: a healthy volunteer study$193,751
R21 · FY2016 · AG · contact PI
CES1 variants as determinant of ACE inhibitor activation: a healthy volunteer study$232,688
R21 · FY2015 · AG · contact PI